Stem Cell Research
Suits filed to invalidate California's $3 billion stem cell institute
Published in Stem Cell Week, March 14th, 2005
One lawsuit filed February 22, 2005, alleges the California Institute for Regenerative Medicine violates state law because it's not governed exclusively by the state government, and the committee that controls the research money it will dole out isn't publicly elected.
The institute was created by California voters when they approved a $3 billion bond to fund stem cell research over the next decade. Proposition 71 was passed by 59% of voters.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
Source: Stem Cell Week (2005-03-14)
More Articles from Stem Cell Week
- Embryonic Stem Cell Research
Human feeder cells support maintenance of embryonic stem cells in culture - Neural Stem Cell Transplantation
Injected neural stem cells migrate to ischemic brain and undergo proliferation - Neural Stem Cell Transplantation
Neural stem cell transplantation remyelinates demyelinated CNS axons - Stem Cell Research
Caspase-3 crucial for osteogenic differentiation of BM stromal stem cells - Testosterone-Producing Cells
Progenitor cells of testosterone-producing Leydig cells revealed - Amyotrophic Lateral Sclerosis
Details discovered on how human stem cells become nerve cells - More from this issue of Stem Cell Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
